Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center

Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center

Abstract Objective Utilizing personalized risk assessment for clinically significant prostate cancer (csPCa) incorporating multiparametric magnetic resonance imaging (mpMRI) reduces biopsies and overdiagnosis. We validated both multi- and univariate risk models in biopsy-naïve men, with and without...

Full description

Bibliographic Details
Main Authors: Philipp Krausewitz, Thomas Büttner, Marthe von Danwitz, Richard Weiten, Alexander Cox, Niklas Klümper, Johannes Stein, Julian Luetkens, Glen Kristiansen, Manuel Ritter, Jörg Ellinger
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Urology
Subjects:
Clinically significant prostate cancer
Prostate biopsy
mpMRI
Risk calculators
Online Access:https://doi.org/10.1186/s12894-024-01460-5

Internet

https://doi.org/10.1186/s12894-024-01460-5

Similar Items